Baotou Dongbao Bio-Tech Co.,Ltd

SZSE:300239 Rapporto sulle azioni

Cap. di mercato: CN¥3.2b

Baotou Dongbao Bio-TechLtd Performance dei guadagni passati

Il passato criteri di controllo 2/6

Baotou Dongbao Bio-TechLtd has been growing earnings at an average annual rate of 35.5%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 18.3% per year. Baotou Dongbao Bio-TechLtd's return on equity is 5.6%, and it has net margins of 10.4%.

Informazioni chiave

35.5%

Tasso di crescita degli utili

32.9%

Tasso di crescita dell'EPS

Chemicals Crescita del settore12.1%
Tasso di crescita dei ricavi18.3%
Rendimento del capitale proprio5.6%
Margine netto10.4%
Ultimo aggiornamento sui guadagni30 Sep 2024

Aggiornamenti sulle prestazioni recenti

Recent updates

Market Might Still Lack Some Conviction On Baotou Dongbao Bio-Tech Co.,Ltd (SZSE:300239) Even After 37% Share Price Boost

Oct 08
Market Might Still Lack Some Conviction On Baotou Dongbao Bio-Tech Co.,Ltd (SZSE:300239) Even After 37% Share Price Boost

We Like These Underlying Return On Capital Trends At Baotou Dongbao Bio-TechLtd (SZSE:300239)

Oct 01
We Like These Underlying Return On Capital Trends At Baotou Dongbao Bio-TechLtd (SZSE:300239)

Baotou Dongbao Bio-TechLtd's (SZSE:300239) Dividend Will Be Reduced To CN¥0.022

May 27
Baotou Dongbao Bio-TechLtd's (SZSE:300239) Dividend Will Be Reduced To CN¥0.022

Sentiment Still Eluding Baotou Dongbao Bio-Tech Co.,Ltd (SZSE:300239)

Feb 28
Sentiment Still Eluding Baotou Dongbao Bio-Tech Co.,Ltd (SZSE:300239)

Ripartizione dei ricavi e delle spese

Come Baotou Dongbao Bio-TechLtd guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.


Storia dei guadagni e delle entrate

SZSE:300239 Ricavi, spese e utili (CNY Millions )
DataRicaviGuadagniSpese G+ASpese di R&S
30 Sep 24873916622
30 Jun 248981066622
31 Mar 249551156824
31 Dec 239751207226
30 Sep 239721176929
30 Jun 239881167028
31 Mar 239771176827
01 Jan 239431096826
30 Sep 229061116423
30 Jun 22812875620
31 Mar 22702565016
01 Jan 22612364013
30 Sep 2156022298
30 Jun 2153919329
31 Mar 2149720309
31 Dec 20449183210
30 Sep 20454204311
30 Jun 20448224211
31 Mar 20469294312
31 Dec 19492334511
30 Sep 19470354311
30 Jun 19454354311
31 Mar 19467354511
31 Dec 18453344510
30 Sep 1843630468
30 Jun 18424274211
31 Mar 1837824418
31 Dec 1735622406
30 Sep 1733022375
30 Jun 1731823430
31 Mar 1731422440
31 Dec 1631719450
30 Sep 1632014490
30 Jun 1631110450
31 Mar 163057410
31 Dec 152926380
30 Sep 152797310
30 Jun 152755310
31 Mar 152604320
31 Dec 142515320
30 Sep 1425912340
30 Jun 1428822330
31 Mar 1433831380
31 Dec 1338243390

Guadagni di qualità: 300239 has high quality earnings.

Margine di profitto in crescita: 300239's current net profit margins (10.4%) are lower than last year (12%).


Flusso di cassa libero e analisi degli utili


Analisi della crescita degli utili nel passato

Andamento degli utili: 300239's earnings have grown significantly by 35.5% per year over the past 5 years.

Accelerare la crescita: 300239's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Guadagni vs Settore: 300239 had negative earnings growth (-22.3%) over the past year, making it difficult to compare to the Chemicals industry average (-3.8%).


Rendimento del capitale proprio

ROE elevato: 300239's Return on Equity (5.6%) is considered low.


Rendimento delle attività


Rendimento del capitale investito


Scoprire le aziende con forti performance passate